"Gene Editing" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Genetic engineering techniques that involve DNA REPAIR mechanisms for incorporating site-specific modifications into a cell's genome.
Descriptor ID |
D000072669
|
MeSH Number(s) |
E05.393.420.270
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Gene Editing".
Below are MeSH descriptors whose meaning is more specific than "Gene Editing".
This graph shows the total number of publications written about "Gene Editing" by people in this website by year, and whether "Gene Editing" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2016 | 0 | 1 | 1 |
2017 | 25 | 12 | 37 |
2018 | 25 | 14 | 39 |
2019 | 21 | 7 | 28 |
2020 | 3 | 2 | 5 |
2021 | 1 | 3 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Gene Editing" by people in Profiles.
-
Applications of CRISPR as a potential therapeutic. Life Sci. 2021 Nov 01; 284:119908.
-
CRISPR-based peptide library display and programmable microarray self-assembly for rapid quantitative protein binding assays. Mol Cell. 2021 09 02; 81(17):3650-3658.e5.
-
Endomembrane targeting of human OAS1 p46 augments antiviral activity. Elife. 2021 08 03; 10.
-
Fast and Efficient Genome Editing of Human FOXP3+ Regulatory T Cells. Front Immunol. 2021; 12:655122.
-
Integrating Omics and Gene Editing Tools for Rapid Improvement of Traditional Food Plants for Diversified and Sustainable Food Security. Int J Mol Sci. 2021 Jul 28; 22(15).
-
Development of safe and highly protective live-attenuated SARS-CoV-2 vaccine candidates by genome recoding. Cell Rep. 2021 08 03; 36(5):109493.
-
Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants. Nature. 2021 07; 595(7866):278-282.
-
COVID-19 one year later: a retrospect of CRISPR-Cas system in combating COVID-19. Int J Biol Sci. 2021; 17(8):2080-2088.
-
Manipulation of genes could inhibit SARS-CoV-2 infection that causes COVID-19 pandemics. Exp Biol Med (Maywood). 2021 07; 246(14):1643-1649.
-
CRISPR/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement. J Zhejiang Univ Sci B. 2021 Apr 15; 22(4):253-284.